Fixational eye movements abnormalities and rate of visual acuity and stereoacuity improvement with part time patching.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
13 01 2021
Historique:
received: 09 10 2020
accepted: 03 12 2020
entrez: 14 1 2021
pubmed: 15 1 2021
medline: 14 8 2021
Statut: epublish

Résumé

Residual amblyopia is seen in 40% of amblyopic patients treated with part-time patching. Amblyopic patients with infantile onset strabismus or anisometropia can develop fusion maldevelopment nystagmus syndrome (FMNS). The purpose of this study was to understand the effects of presence of FMNS and clinical subtype of amblyopia on visual acuity and stereo-acuity improvement in children treated with part-time patching. Forty amblyopic children who had fixation eye movement recordings and at least 12 months of follow-up after initiating part-time patching were included. We classified amblyopic subjects per the fixational eye movements characteristics into those without any nystagmus, those with FMNS and patients with nystagmus without any structural anomalies that do not meet the criteria of FMNS or idiopathic infantile nystagmus. We also classified the patients per the clinical type of amblyopia. Patching was continued until amblyopia was resolved or no visual acuity improvement was noted at two consecutive visits. Children with anisometropic amblyopia and without FMNS have a faster improvement and plateaued sooner. Regression was only seen in patients with strabismic/mixed amblyopia particularly those with FMNS. Patients with FMNS had improvement in visual acuity but poor stereopsis with part-time patching and required longer duration of treatment.

Identifiants

pubmed: 33441575
doi: 10.1038/s41598-020-79077-5
pii: 10.1038/s41598-020-79077-5
pmc: PMC7806581
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1217

Références

Ophthalmology. 2001 Jan;108(1):163-71
pubmed: 11150283
Dev Sci. 2011 Nov;14(6):1330-9
pubmed: 22010893
Invest Ophthalmol Vis Sci. 2017 Nov 1;58(13):5743-5753
pubmed: 29114840
Doc Ophthalmol. 1989 Aug;72(3-4):375-84
pubmed: 2625098
J Neuroophthalmol. 2010 Sep;30(3):276-83
pubmed: 20818206
Invest Ophthalmol Vis Sci. 2014 Aug 05;55(8):5332-7
pubmed: 25097243
Prog Brain Res. 2019;249:235-248
pubmed: 31325983
Strabismus. 2009 Sep;17(3):107-16
pubmed: 20804358
J AAPOS. 2013 Jun;17(3):287-90
pubmed: 23791411
Graefes Arch Clin Exp Ophthalmol. 2007 Jun;245(6):811-6
pubmed: 17047980
PLoS One. 2017 Apr 13;12(4):e0175295
pubmed: 28406944
Vision Res. 2013 Aug 30;89:65-71
pubmed: 23891704
Ophthalmology. 2003 Aug;110(8):1632-7; discussion 1637-8
pubmed: 12917184
Arch Ophthalmol. 2003 May;121(5):603-11
pubmed: 12742836
Ophthalmology. 2003 Nov;110(11):2075-87
pubmed: 14597512
Arch Ophthalmol. 2011 Nov;129(11):1451-7
pubmed: 21746970
PLoS One. 2020 Aug 13;15(8):e0237346
pubmed: 32790721
Neuroscience. 2008 Oct 2;156(2):403-11
pubmed: 18708128
Am J Ophthalmol. 2007 Jan;143(1):54-60
pubmed: 17113556
Arch Ophthalmol. 2002 Mar;120(3):268-78
pubmed: 11879129
J Vis. 2014 Feb 25;14(2):
pubmed: 24569984
Br J Ophthalmol. 1995 Mar;79(3):225-8
pubmed: 7703198
Vision Res. 2011 Oct 15;51(20):2216-23
pubmed: 21911002
J AAPOS. 2019 Apr;23(2):98.e1-98.e4
pubmed: 30935990
Science. 1992 Jan 10;255(5041):209-12
pubmed: 1372754
Can J Ophthalmol. 2012 Oct;47(5):399-409
pubmed: 23036539
Vision Res. 2005 Mar;45(7):827-37
pubmed: 15644223
Am J Ophthalmol. 2018 Feb;186:104-115
pubmed: 29196184
PLoS One. 2016 Mar 01;11(3):e0149953
pubmed: 26930079
Ophthalmology. 2006 Nov;113(11):2097-100
pubmed: 17074568
J Neurosci. 2001 May 15;21(10):3476-82
pubmed: 11331376
Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3805-17
pubmed: 11053280
Am J Ophthalmol. 1987 Jan 15;103(1):87-9
pubmed: 3799793
Ophthalmology. 2006 Jun;113(6):895-903
pubmed: 16751032
Prog Brain Res. 2006;154:151-76
pubmed: 17010709
Prog Retin Eye Res. 2013 Mar;33:67-84
pubmed: 23201436
Trans Am Ophthalmol Soc. 1999;97:987-1021
pubmed: 10703148
JAMA Ophthalmol. 2015 May;133(5):606-9
pubmed: 25695355
Arch Ophthalmol. 2007 May;125(5):655-9
pubmed: 17502505
Invest Ophthalmol Vis Sci. 2018 Sep 4;59(11):4506-4517
pubmed: 30208418
Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2589-94
pubmed: 17525188
Optom Vis Sci. 1992 Oct;69(10):747-54
pubmed: 1436994
Invest Ophthalmol Vis Sci. 2012 Aug 09;53(9):5386-94
pubmed: 22789926
Invest Ophthalmol Vis Sci. 2013 Mar 19;54(3):1998-2003
pubmed: 23372053
Ann N Y Acad Sci. 2002 Apr;956:346-60
pubmed: 11960818
J AAPOS. 2007 Jun;11(3):240-2
pubmed: 17419081
PLoS One. 2013;8(2):e56556
pubmed: 23441203
J AAPOS. 2005 Dec;9(6):510-21
pubmed: 16414515
Trans Am Ophthalmol Soc. 2007;105:564-93
pubmed: 18427630
Strabismus. 2002 Jun;10(2):95-105
pubmed: 12221487
Indian J Ophthalmol. 2013 Nov;61(11):630-3
pubmed: 24343594
J AAPOS. 2004 Oct;8(5):420-8
pubmed: 15492733
Ophthalmology. 2007 Aug;114(8):1427-32
pubmed: 17363058
Arch Ophthalmol. 2005 Feb;123(2):149-57
pubmed: 15710809
Ophthalmology. 2019 Mar;126(3):456-466
pubmed: 30352226

Auteurs

Matteo Scaramuzzi (M)

Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA.
Department of Neuroscience, Unit of Ophthalmology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
DISCCO, University of Milan, Milan, Italy.

Jordan Murray (J)

Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA.

Paolo Nucci (P)

DISCCO, University of Milan, Milan, Italy.

Aasef G Shaikh (AG)

Daroff-Dell'Osso Ocular Motility Laboratory, Cleveland, OH, USA.
Case Medical Center, Case Western Reserve University, Cleveland, OH, USA.

Fatema F Ghasia (FF)

Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA. fatemaghasia@gmail.com.
Case Medical Center, Case Western Reserve University, Cleveland, OH, USA. fatemaghasia@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH